Pharmacists on the front line in providing support for nicotine replacement therapy and bupropion purchasers

References

• World Health Organisation. The World Health Report 2002. Reducing risks, promoting healthy life. World Health Organisation, Geneva 2002
   Google Scholar
• Jacobs D R, Jr, Adachi H, Mulder I, et al. Cigarette smoking and mortality risk: twenty-five-year follow-up of the Seven Countries Study. Arch Intern Med 1999; 159: 733–740
   PubMed Web of Science ®Google Scholar
• Hughes J R, Goldstein M G, Hurt R D, Shiffman S. Recent advances in the pharmacotherapy of smoking. JAMA 1999; 281: 72–76
   PubMed Web of Science ®Google Scholar
• Fiore M C, Bailey W C, Cohen S J, et al. Treating tobacco use and dependence. Clinical Practice Guideline. US Department of Health and Human Services, Rockville, MD 2000
   Google Scholar
• Silagy C, Lancaster T, Stead L, Mant D, Fowler G. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 2004, 3
   Google Scholar
• Walsh R A, Penman A G. The effectiveness of nicotine replacement therapy over-the-counter [Editorial]. Drug Alcohol Rev 2000; 19: 243–247
   Web of Science ®Google Scholar
• Sonderskov J, Olsen J, Sabroe S, Meillier L, Overvad K. Nicotine patches in smoking cessation: a randomized trial among over-the-counter customers in Denmark. Am J Epidemiol 1997; 145: 309–318
   PubMed Web of Science ®Google Scholar
• Sinclair H K, Bond C M, Lennox A S, Taylor R J, Winfield A J. Nicotine replacement therapies: smoking cessation outcomes in a pharmacy setting in Scotland. Tob Control 1995; 4: 338–343
   Google Scholar
• Doran C M, Shakeshaft A P, Gates J A, Fawcett J E, Mattick R P. Current prescribing patterns of bupropion in Australia. Med J Aust 2002; 177: 162
   PubMedGoogle Scholar
• Burton B. Australia turns to drug company representatives to cut prescribing. BMJ 2002; 324: 1234a
   Google Scholar
• Shiffman S, Rolf C N, Hellebusch S J, et al. Real-world efficacy of prescription and over-the-counter nicotine replacement therapy. Addiction 2002; 97: 505–516
   PubMed Web of Science ®Google Scholar
• Thorndike A N, Biener L, Rigotti N A. Effect on smoking cessation of switching nicotine replacement therapy to over-the-counter status. Am J Public Health 2002; 92: 437
   PubMed Web of Science ®Google Scholar
• Pierce J P, Gilpin E A. Impact of over-the-counter sales on effectiveness of pharmaceutical aids for smoking cessation. JAMA 2002; 288: 1260–1264
   PubMed Web of Science ®Google Scholar
• Chapman S, Borland R. Advertising of nicotine replacement therapy: has it promoted more smoking cessation?. Smith Kline Beecham Consumer Healthcare 1999; 2–7
   Google Scholar
• Paul C, Walsh R A, Girgis A. Nicotine replacement therapy products over the counter: real-life use in the Australian community. Aust NZ J Public Health 2003; 27: 491–495
   PubMed Web of Science ®Google Scholar
• Australia's National Tobacco Campaign, K Hassard, et al. Commonwealth Department of Health and Aged Care, Canberra 1999, evaluation: report vol 1
   Google Scholar
• Hudmon K, Hemberger K, Corelli R, et al. The pharmacist's role in smoking cessation counselling: perceptions of users of non-prescription nicotine replacement therapy. J Am Pharm Assoc 2003; 43: 573–582
   Google Scholar
• Sinclair H K, Bond C M, Lennox A S, Silcock J, Winfield A J, Donnan P T. Training pharmacists and pharmacy assistants in the stage-of-change model of smoking cessation: a randomised controlled trial in Scotland. Tob Control 1998; 7: 253–261
   PubMed Web of Science ®Google Scholar
• Maguire T A, McElnay J C, Drummond A. A randomized controlled trial of a smoking cessation intervention based in community pharmacies. Addiction 2001; 96: 325–331
   Google Scholar
• Carroll P, Fois R, Sarson D, Flynn J. A community pharmacy-based smoking cessation program using transdermal nicotine replacement therapy—actions and outcomes. Aust Pharm 2000; 19: 51–55
   Google Scholar
• Couchenour R L, Denham A Z, Simpson K N, Lahoz M R, Carson D S. Smoking cessation activities in South Carolina community pharmacies. J Am Pharm Assoc 2000; 40: 828–831
   Google Scholar
• Williams D M, Newsom J F, Brock T P. An evaluation of smoking cessation-related activities by pharmacists. J Am Pharm Assoc 2000; 40: 366–370
   Google Scholar
• O'Loughlin J, Masson P, Dery V, Fagnan D. The role of community pharmacists in health education and disease prevention: a survey of their interests and needs in relation to cardiovascular disease. Prev Med 1999; 28: 324–331
   Google Scholar
• Paul C L, Walsh R A, Tzelepis F. A monetary incentive increases postal survey response rates for pharmacists. J Epidemiol Commun Health 2005; 59: 1099–1101
   PubMed Web of Science ®Google Scholar
• Lancaster T, Stead L, Silagy C, Sowden A. Effectiveness of interventions to help people stop smoking: findings from the Cochrane Library. BMJ 2000; 321: 355–358
   PubMed Web of Science ®Google Scholar